Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 54 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Walsh, Thomas J [Clear All Filters]
Increased virulence of Cunninghamella bertholletiae in experimental pulmonary mucormycosis: correlation with circulating molecular biomarkers, sporangiospore germination and hyphal metabolism..
Med Mycol. 51(1), 72-82.
(2013). A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts..
Intensive Care Med. 39(12), 2092-106.
(2013). What can we learn and what do we need to know amidst the iatrogenic outbreak of Exserohilum rostratum meningitis?.
Clin Infect Dis. 57(6), 853-9.
(2013). Candida osteomyelitis: analysis of 207 pediatric and adult cases (1970-2011)..
Clin Infect Dis. 55(10), 1338-51.
(2012). Combination therapy for mucormycosis: why, what, and how?.
Clin Infect Dis. 54 Suppl 1, S73-8.
(2012). Epidemiology and clinical manifestations of mucormycosis..
Clin Infect Dis. 54 Suppl 1, S23-34.
(2012). Host defenses against zygomycetes..
Clin Infect Dis. 54 Suppl 1, S61-6.
(2012). How does antifungal pharmacology differ for mucormycosis versus aspergillosis?.
Clin Infect Dis. 54 Suppl 1, S67-72.
(2012). Invasive aspergillosis in children with acquired immunodeficiencies..
Clin Infect Dis. 54(2), 258-67.
(2012). Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model..
Antimicrob Agents Chemother. 56(1), 403-10.
(2012). Results from a prospective, international, epidemiologic study of invasive candidiasis in children and neonates..
Pediatr Infect Dis J. 31(12), 1252-7.
(2012). Rhino-orbital-cerebral mucormycosis..
Curr Infect Dis Rep. 14(4), 423-34.
(2012). Activities of triazole-echinocandin combinations against Candida species in biofilms and as planktonic cells..
Antimicrob Agents Chemother. 55(5), 1968-74.
(2011). Antifungal activity of posaconazole and granulocyte colony-stimulating factor in the treatment of disseminated zygomycosis (mucormycosis) in a neutropaenic murine model..
Mycoses. 54(5), e486-92.
(2011). Differential transcriptional profiles induced by amphotericin B formulations on human monocytes during response to hyphae of Aspergillus fumigatus..
Med Mycol. 49(2), 176-85.
(2011). Effects of interferon-γ and granulocyte colony-stimulating factor on antifungal activity of human polymorphonuclear neutrophils against Candida albicans grown as biofilms or planktonic cells..
Cytokine. 55(3), 330-4.
(2011). Immunomodulatory properties of antifungal agents on phagocytic cells..
Immunol Invest. 40(7-8), 809-24.
(2011). Synergistic interaction of the triple combination of amphotericin B, ciprofloxacin, and polymorphonuclear neutrophils against Aspergillus fumigatus..
Antimicrob Agents Chemother. 55(12), 5923-9.
(2011). Comparative pharmacodynamic interaction analysis of triple combinations of caspofungin and voriconazole or ravuconazole with subinhibitory concentrations of amphotericin B against Aspergillus spp..
Mycoses. 53(3), 239-45.
(2010). Cunninghamella bertholletiae exhibits increased resistance to human neutrophils with or without antifungal agents as compared to Rhizopus spp..
Med Mycol. 48(5), 720-4.
(2010). Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi.
Antimicrob Agents Chemother. 54(2), 602-9.
(2010). Fungal biomass is a key factor affecting polymorphonuclear leucocyte-induced hyphal damage of filamentous fungi..
Mycoses. 53(4), 321-8.
(2010). Interactions between human phagocytes and Candida albicans biofilms alone and in combination with antifungal agents..
J Infect Dis. 201(12), 1941-9.
(2010). Aspergillus and the paediatric lung..
Paediatr Respir Rev. 10(4), 178-85.
(2009).
(2009).